Five Years of CViSB
CViSB is 5 years old as of this February! Looking back, we have made significant strides toward our goal of identifying the human and viral factors that determine the outcome of infection with Lassa, Ebola, and SARS-CoV-2 viruses. CViSB’s multi-disciplinary team has collected clinical, immunological, and genomic data, combined multi-omics technologies and applied high-throughput (HTP) experiments to our unique patient…
Michelle McGrawMarch 24, 2023